share_log

JP Morgan Maintains Underweight on Enanta Pharma, Lowers Price Target to $11

Moomoo 24/7 ·  Feb 8 16:43

JP Morgan analyst Eric Joseph maintains Enanta Pharma (NASDAQ:ENTA) with a Underweight and lowers the price target from $12 to $11.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment